Skip to main content

Table 6 Medications used in hospitalised patients with COVID-19

From: Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates

Medications N (%)
HCQ 5945 (63.31%)
Favipiravir 5057 (53.86%)
Enoxaparin 4359 (46.42)
Camostat 1094 (11.65%)
Lopinavir/ritonavir 849 (9.04%)
Azithromycin 595 (6.34%
Chloroquine 260 (2.77%)
Tocilizumab 23 (2.5%)
Steroidsa 188 (2%)
Doxycycline 104 (1.1%)
Heparin 102 (1%)
  1. aSteroids: dexamethasone, methylprednisolone Na succinate and prednisolone